Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice.

bioRxiv : the preprint server for biology·2026
Same author

Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank study.

Brain : a journal of neurology·2026
Same author

Functional Activity of TDP 43: A Direct Biomarker for ALS.

medRxiv : the preprint server for health sciences·2026
Same author

Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration.

Science (New York, N.Y.)·2026
Same author

Technology Dependence in Educational Practice: Evaluating the Scientific and Practical Impacts.

Nursing education perspectives·2026
Same author

The Year Ahead: Nursing Educational Technology Trends for 2026.

Nursing education perspectives·2026

Related Experiment Video

Updated: Jun 20, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Intrathecal (G4C2)149 delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS/FTD pathological

Katelyn A Russell1,2, Amelia A Shahrabi1,2, Suleyman C Akerman3,4

  • 1Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

Acta Neuropathologica Communications
|June 19, 2026
PubMed
Summary

A new mouse model effectively mimics amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) by using a viral vector to express C9ORF72 repeats in the central nervous system (CNS), revealing key disease mechanisms.

Keywords:
ALSALS/FTDC9orf72C9orf72 repeat expansionsFTDMotor neuron diseaseMouse modelsNeurodegenerative disease

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

Related Experiment Videos

Last Updated: Jun 20, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • C9ORF72 repeat expansions are the leading genetic cause of ALS and FTD.
  • Existing mouse models do not fully recapitulate spinal cord pathology relevant to these diseases.

Purpose of the Study:

  • To develop a more comprehensive mouse model for ALS and FTD by targeting the C9ORF72 gene.
  • To investigate both gain- and loss-of-function mechanisms contributing to disease pathogenesis.

Main Methods:

  • Adeno-associated virus (AAV) encoding (G4C2)149 repeats was administered intrathecally in neonatal mice.
  • Mice with varying degrees of endogenous C9orf72 loss were utilized.
  • Longitudinal analyses included motor function, behavior, and neuropathology.

Main Results:

  • Widespread CNS expression with significant spinal cord targeting was achieved.
  • Repeat expression led to progressive muscle weakness and subtle gait abnormalities.
  • Spinal motor regions showed dipeptide repeat protein accumulation, motor neuron loss, glial activation, and TDP-43 alterations.

Conclusions:

  • This AAV-based approach creates a coherent, mild mouse model of ALS/FTD.
  • The model effectively links C9ORF72 repeat expression, spinal pathology, and motor dysfunction.
  • It provides a valuable tool for studying ALS and FTD pathogenesis and for therapeutic development.